Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Safety and Pharmacokinetics Study of Single Dose Dexmedetomidine Transdermal System in Healthy Subjects

Trial Profile

A Safety and Pharmacokinetics Study of Single Dose Dexmedetomidine Transdermal System in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Aug 2018

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions
  • Sponsors Teikoku Pharma USA
  • Most Recent Events

    • 22 Aug 2018 Status changed from recruiting to completed.
    • 09 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top